Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRD vs Melphalan/SCT in Newly Diagnosed Multiple Myeloma
NCT01091831Phase 3Completed
- Sponsor
- Fondazione EMN Italy
- Start
- Jul 2009
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide in multiple myeloma (MM), sponsored by Fondazione EMN Italy. Started Jul 2009; status: completed.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01091831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01091831.